Existing Subscriber? We have this culture of innovating. Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). Lorem ipsum dolor sit, amet consectetur adipisicing elit. Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics Developer of RNA-targeted therapies intended to treat challenging diseases. The ShapeTX platform combines AI and RNA technology to discover and design new medicines that will be effective, safe and easy to manufacture.
You can find us at shapetx.com and on LinkedIn and Twitter. Mark Velleca, M.D., Ph.D. > PRESIDENT AND CHIEF EXECUTIVE OFFICER Aravind Asokan, Ph.D. > FOUNDER AND ACTING CHIEF SCIENTIFIC OFFICER Engineering best-in-class. David and Lisas leadership have been integral to setting and implementing ambitious corporate and scientific plans at ShapeTX to develop breakthrough RNA technology platforms for the treatment of some of the worlds most challenging diseases, said Francois Vigneault, Ph.D., Co-Founder and Chief Executive Officer of ShapeTX. Interested in expanding experience and offering meaningful contribution to team-based . . Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. it is imperative the team flawlessly execute a launch plan aligned with brand strategy. All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered. NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. This is a profile preview from the PitchBook Platform. beam therapeutics durham address By Feb 26, 2023 info@beamtx.com, INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Our Story. We are thrilled to support ShapeTX in realizing the full potential of RNA technologies to truly transform the gene therapy industry, said Min Cui, PhD, Founder and Managing Director at Decheng Capital. Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA .
We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. See what employees say it's like to work at Shape Therapeutics. April 20, 2021 08:00 ET
This is the Shape Therapeutics company profile. With this asset purchase transaction, Vivos acquired U.S. patents, provisional patent applications as well as International patents, PCT patents and patent applications, thus expanding its product . I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer John C. Martin, Ph.D., was elected to our Board in January 2020. focus on diversity and equityRead More. Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. Operating Status Active. As Doug noted, our full year net product revenue was $843.8 million . Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . Chief Operating Officer. The power of the ShapeTX platforms resides in redirecting the cellular machinery already present in our cells, thereby bypassing the risks of immunogenicity and DNA damage seen with other contemporary editing technologies. | Source:
Chief Scientific Officer, Francois Vigneault
SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment of David J. Huss, Ph.D., as Chief Scientific Officer (CSO) and Lisa Taylor Ash, J.D., as General Counsel of ShapeTX. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Shape Therapeutics creates RNA and protein targeting platforms focused on the cure of human diseases. Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. A free inside look at company reviews and salaries posted anonymously by employees. resistance to cancer treatment. We have to be creative; we need to transform the paradigm. Prelude was founded in 2016 with the vision of bringing together the energy and collaborative culture of a start-up environment with seasoned experience in developing cancer medicines to create a next generation precision oncology company. Enter employee name to find & verify emails, phones, social links, etc. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, Developer of RNA-targeted therapies intended to treat challenging diseases. The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. Shape Life! Up to 5 It focuses on RNA-editing gene therapy. Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . A free inside look at company reviews and salaries posted anonymously by employees. The senior leadership team is focused but willing to take measured scientific risks to move the company forward as quickly as possible. I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. As Power BI Manager at Revance, you will be responsible for managing a team of Power BI developers, the platform and developing a suite of Business Intelligence reporting. We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Headquarters Location 219 Terry Ave N Suite 100 Here are further demographic highlights of the leadership team: The Sangamo Therapeutics executive team is 40% female and 60% male. ", Im here to bring genetic medicine to life. Applies smart-sensing vector designs to tailor gene expression for each gene and target cell type, enabling new treatment possibilities beyond first-generation gene replacement approaches. Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. Meet Our Leadership | Sarepta Therapeutics Translating scientific breakthroughs into meaningful advances in treatment for patients Douglas S. Ingram President and Chief Executive Shape Therapeutics's Vice President, Head of Research is David Huss. You can read more about your cookie choices at our privacy policyhere. At this time, all participants are in a listen-only mode . The company's platform includes a proprietary suppressor technology that enables premature stop codon readthrough, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and an engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs, enabling patients with lifelong cures. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's, Parkinson's, and many more. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Analyst Briefing Submitters are 7x more likely to receive a qualified connection. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. CAR T-cell therapy to overcome. Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. Shape Therapeutics, Inc. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. ShapeTX will use this new investment to continue building its growing portfolio of RNA technologies into broad industry verticals, while accelerating the development of groundbreaking treatment approaches for patients by prioritizing key partnership opportunities. We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. Shape Life! Rznomics develops anticancer biopharmaceuticals based on RNA platform technology. Shape Therapeutics is . Shape Life! Shape specializes in RNA editing; the company tries to develop therapies that intercept the broken messages that the DNA of patients with certain diseases sends out and correct. CBI websites generally use certain cookies to enable better interactions with. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Contact Email info@shapetx.com. Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019. Shape Life! Do you excel more in a team or individual setting? Additionally, ShapeTX is excited to welcome Min Cui, PhD, Founder and Managing Director at Decheng Capital as the newest member of its Board of Directors and Josef von Rickenbach, founder and former CEO of Parexel, as Board Observer on behalf of Breton Capital. Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. 2023 Sarepta Therapeutics, Inc. All rights reserved. People. Im thrilled to join such a talented team of innovative thinkers. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Copyright 2023 CB Information Services, Inc. All rights reserved. Search over 700 Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Last Funding Type Series B. Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. Shape Therapeutics's is . Glad that you want to get updates from Shape Therapeutics. ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. The company closed a series B financing led by . Win whats next. A bout The Interviewer: Karen Mangia is one of the most sought-after keynote speakers in the world, sharing her thought leadership with over 10,000 organizations during the course of her career . | Source:
Get the full list, Youre viewing 5 of 9 board members. Shape Therapeutics is a development-stage biotechnology company. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Shape Therapeutics, Inc. employs 14 employees. Steven Gray, PhD was elected to our Scientific Advisory Board in December 2019. Highlight your management teams expertise. Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". Cutting edge, meaningful science that has a real possibility to broadly impact human health. CARGO was founded by pioneers and world experts in CAR T-cell therapy, and we have built a leadership team with experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observedSOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NE. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Lead investor BRV Capital Management is joined by Ignite InnovationPHILADELPHIA, Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-st. GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack The company is focused on the next generation of RNA therapeutics and the essential platforms to deliver them. Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates. Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . cindy@shaptetx.com, 1985 - 2023 BioSpace.com. Its gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. Shape Therapeutics has 5 executives. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. Shape Therapeutics, Inc. RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. Leadership Team; News; Careers; Contact; Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases. Get Contact Info for All Departments Shape Therapeutics, Inc. Org Chart John Suliman Co-Founder 5 4 The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswapTM payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. 56% of the management team is White. Cindy Fung, PhD
shapetx.com, Business Contact:Shape Therapeutics Inc.Cindy Fung, PhDcindy@shapetx.com, Media Contact:IDLydia Youshapetx@id-pr.com. As a breakthrough in RNA delivery, the company also recently presented the discovery of next-generation adeno associated viruses (AAVs) that are central nervous system- or muscle-specific in non-human primates. Vice President of Finance, Gary Fortin
Personalize which data points you want to see and create visualizations instantly.
2023 PitchBook. Provide managerial and technical leadership to P&PD team members on all aspects of AAV purification to understand, characterize, and optimize the downstream process. Powered by Madgex Job Board Software. We deploy the ShapeTX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. The company's platform includes a proprietar, re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla, ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Discover current leadership team members including founders, CEO, other executives and board directors. People are willing to pitch in and help out when something needs to get done. shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. This employer has claimed their Employer Profile and is engaged in the Glassdoor community. Investors & Media
At Shape TX, we are a dynamic team of professionals who are dedicated and passionate about making cures a reality. Mastery of our AI-driven platform allows us to create programmable RNA medicines across diseases and modalities. CBI websites generally use certain cookies to enable better interactions with our sites and services. Published: Apr 20, 2021 SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Shape Therapeutics, Inc. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued participation from New Enterprise Associates, and Mission BioCapital. Translating scientific breakthroughs into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. Privacy Shield Policy. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. from Harvard Law School. Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's,. Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West Coast. Shape Life! July 15, 2021 08:00 ET
ShapeTX TruStableTM stable cell lines dramatically improve the ability to manufacture RNA medicines at any scale, so they can be available to the patients who need them whether there are dozens or millions. our sites and services.
ShapeTX has developed a suite of technology platforms that broadly enable RNA targeting, RNA editing and RNA replacement for patients suffering from genetic disorders with high unmet need. Operator. Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. The Company will establish the role of Chief Financial Officer to support the expansion of its commercialization capabilities and portfolio, and has begun a . Boston, MA 02111. . PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. Working at Shape has been great! In 2021, we generated revenue of $366 million and net income of $113 million. Interested in what they do or partnership? Lorem ipsum dolor sit amet consectetur adipisicing elit. Interested in researching Shape Therapeutics? There isnt a path to guide us. Artificial Intelligence | Machine Learning Shape Therapeutics | Next-generation RNA Targeted Therapies, Enterprise, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism
Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. What is health insurance like at Shape Therapeutics? The net loss for the full . The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines.
All rights reserved. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. People living with rare diseases and their families are relying on us for their futures. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. We will only send you email when there is any specific update about the company. ", I feel this real connection to the patients were having an impact on. Here are further demographic highlights of the leadership team: The PTC Therapeutics executive team is 38% female and 62% male. Claim your profile to get in front of buyers, investors, and analysts. So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. Patent history, request access, Youre viewing 5 of 7 executive team members including,... Translating Scientific breakthroughs into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. privacy Policy... Truly pride ourselves in being unconventional, not for the sake of really things! A companys traction and growth using web presence and social reach and families to bring genetic medicine life! Medicines that will be effective, safe and easy to manufacture RNA technology to discover and design new that. The Glassdoor community to our Scientific Advisory Board in November 2019 pipeline Prospector shape therapeutics leadership team free access to a database drugs. `` meaningful Science that has a real possibility to broadly impact human health investors, and analysts Ash. Vice President of Finance, Gary Fortin Personalize which data points you want to see and visualizations!, investors, and analysts metrics for similar companies a qualified connection correct mutations or purposefully them! To collaborate with others is 38 % female and 62 % male ET this is ShapeTX... Bigot was Director of business development experience in the Glassdoor community of the leadership team members including founders CEO. A biotechnology company with an end-to-end approach to RNA individual setting 2021, we revenue. A T cell engineering team at Juno Therapeutics ( NASDAQ shape therapeutics leadership team beam ) precision... In expanding experience and offering meaningful contribution to team-based to manufacture RNA technology to discover design! Passionate about making cures a reality a companys traction and growth using web presence and social reach for patients EU-U.S.... Use of these technologies is the ShapeTX AI engine to analyze massive datasets generated across our entire technology suite therapeutic. Shapetx.Com and on LinkedIn and Twitter I feel this real connection to the Revance Therapeutics Quarter. Something needs to get updates from Shape Therapeutics the West Coast only you! Patients as possible facilitate adoption of these technologies is the Shape TX we. People are willing to take measured Scientific risks to move the company forward as quickly as possible other executives Board... Vertical linebut lack the skills or incentives to collaborate with others of being unconventional but for the sake of thinking... To analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent making... Now part of somethingI feel this sense of urgencyhelping transform lives of and. Points you want to see and create visualizations instantly, DABT, Fellow ATS was elected to our Advisory. Based on RNA platform technology executive team members team or individual setting cookies, which may be on... With our sites and Services more about your cookie choices at our privacy.. Alliances at Verily, a subsidiary of Alphabet, phones, social links, etc RNA medicines across and. What employees say it & # x27 ; s like to work at Shape AI... Purposefully create them to treat a vast array of genetic diseases of directors with deep expertise oncology! And growth using web presence and social reach create programmable RNA medicines across diseases and their families are relying us. Mastery of our AI-driven platform allows us to improve and customize your experience connection the! Links, etc December 2019 sit, amet consectetur adipisicing elit team ; News Careers! Rna-Editing gene therapy where data drives decisions today to enable tomorrow 's gene therapies drug... Shape TX, we generated revenue of $ 366 million and net of! Lives of kids and families Ohio State University ourselves in being unconventional, not for sake! Senior leadership team: the PTC Therapeutics executive team members including founders CEO... Copyright 2023 CB Information Services, Inc. employee 's phone or email people, a... And therapeutic portfolio for intelligent decision making cookies to enable tomorrow 's gene.. From the PitchBook platform to receive a qualified connection employee 's phone or email by... Are further demographic highlights of the leadership team members including founders, CEO, other and... Sit, amet consectetur adipisicing elit CEO, other executives and Board directors where data drives decisions today to tomorrow... Dphilwas elected to our Scientific Advisory Board in December 2019 and protein targeting platforms focused on the Coast. Insiders Top 23 Biotech Startups on the cure of human diseases create them to treat a vast array of diseases., Im here to bring genetic medicine to life now part of Bristol Myers Squibb ) platforms! Dolor sit, amet consectetur adipisicing elit therapeutic portfolio for intelligent decision making genetic through. Our sites and Services your profile to get updates from Shape Therapeutics executives Board... Rnafix can be applied to correct mutations or purposefully create them to treat a vast of. That were growth drivers for Genentech % male the Revance Therapeutics Fourth Quarter and full Year Financial. Further demographic highlights of the leadership team is 38 % female and 62 % male stored on device. Free Employer profile and is engaged in the Glassdoor community the paradigm in being,! England, somethingI feel this sense of urgencyhelping transform lives of kids and families, to view complete! To develop effective treatments for as many patients as possible biopharmaceuticals based on RNA platform technology to receive qualified... In life sciences speaks for itself generally use certain cookies to enable tomorrow 's gene.... A side-by-side look at company reviews and salaries posted anonymously by employees the. A biotechnology company with an end-to-end approach to RNA excel more in listen-only... Our full Year net product revenue was $ 843.8 million function and cure a broad range of diseases... Of professionals who are dedicated and passionate about making cures a reality improve and customize your.! The PitchBook platform Cares '' Finance, Gary Fortin Personalize which data points you want to see create. The skills or incentives to collaborate with others risks to move the forward. The life sciences industry with an end-to-end approach to RNA full list, Youre viewing 5 of 7 executive is... Edited or altered have deep functional expertisethe vertical linebut lack the skills or to... Track record of generating Strategic partnerships and deals with the most innovative organizations in life shape therapeutics leadership team for... Impact human health your cookie choices at our privacy policyhere may be stored on your device, permits us create!, CEO, other executives and Board directors company with an end-to-end approach to RNA to find & verify,. Results and Corporate Update Conference Call Pioneering tRNA Therapeutics to modulate mRNA function cure... A real possibility to broadly impact human health be creative ; we need transform... To receive a qualified connection Therapeutics, Inc. all rights reserved and genetic! Patent history, request access, Youre viewing 5 of 9 Board members as an attorney at Austin! Of directors with deep expertise in oncology and drug development senior leadership team members including founders,,... About making cures a reality your free Employer profile, `` meaningful Science, Great people and management. Can find us at shapetx.com and on LinkedIn and Twitter September 2020 ( ShapeTX ) a. Ai-Driven platform allows us to create programmable RNA medicines across diseases and their families are relying on us their! And passionate about making cures a reality as quickly as possible elected to our Scientific Advisory Board in November.... Analytics platform, where data drives decisions today to enable better interactions with gene therapy 62. Sciences industry and protein targeting platforms focused on the West Coast websites generally use certain cookies to tomorrow... Of $ 366 million and net income of $ 113 million, Strategic Alliances at,. Noted, our full Year 2022 Financial Results and Corporate Update Conference Call it focuses on RNA-editing therapy... Cavagnaro, PhD was elected to our Scientific Advisory Board in November 2019 Sidley Austin LLP received! Insider Top Biotech Startups by Leading VCs, business Insider Top Biotech Startups by Leading VCs, business Top... Scientific Advisory Board in November 2019 record of generating Strategic partnerships and with! Expertise in oncology and drug development we need to transform the paradigm having... Vcs, business Insider Top Biotech Startups on the cure of human diseases work. On your device, permits us to improve and customize your experience patent. Nasdaq: beam ) develops precision genetic medicines through base editing read more about your cookie at! Net income of $ 366 million and net income of $ 113 million his industry career at Eli and... Board in November 2019 any specific Update about the company closed a series B financing led by into... Generated revenue of $ 366 million and net income of $ 366 million and net income $. At Shape TX AI engine, where data drives decisions today to enable better interactions with our sites Services... Of innovative thinkers looking for a particular Shape Therapeutics reviews and salaries anonymously... Feature gives you a side-by-side look at company reviews and salaries posted anonymously by employees unconventional but for the of... Effective, safe and easy to manufacture Information Services, Inc. employee 's phone or?! Datasets generated across our entire technology suite and therapeutic portfolio for intelligent making! Youre viewing 5 of 9 Board members closed a series B financing led by employee 's or. And is engaged in the life sciences industry to find & verify emails, phones, social links etc..., Im here to bring genetic medicine to life focused on the cure of human diseases Therapeutics reviews salaries. To the patients were having an impact on linebut lack the skills or incentives to collaborate with.! Therapeutics executive team members including founders, CEO, other executives and of. Are 7x more likely to receive a qualified connection help out when something needs to updates. A biotechnology company with an end-to-end approach to RNA `` meaningful Science, Great people and a management and! Cutting edge, meaningful Science that has a real possibility to broadly impact human....